Search results
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 3 months agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript May 2, 2024 Ultragenyx...
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks via Yahoo Singapore Finance· 3 months agoUltragenyx (RARE) reports dismal first-quarter 2024 results, missing both earnings and revenue...
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag
Reuters via Yahoo Singapore Finance· 4 months agoThe therapy was approved on Monday, in a first for children with a rare disorder called...
UPDATE 1-US approves first gene therapy for children with rare genetic disease
Reuters via Yahoo Singapore Finance· 4 months agoThe U.S. health regulator on Monday approved UK-based Orchard Therapeutics' gene therapy to treat children with metachromatic leukodystrophy (MLD), making it the first approved treatment in ...
BridgeBio Pharma Inc (BBIO) Reports Q4 and Full Year 2023 Financials, Advances Key Clinical Trials
GuruFocus.com via Yahoo Singapore Finance· 5 months agoRevenue: Reported a decrease to $9.3 million for the full year 2023 from $77.6 million in the...
Q4 2023 Ultragenyx Pharmaceutical Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Singapore Finance· 5 months agoParticipants Emil D. Kakkis; Founder, President, CEO & Director; Ultragenyx Pharmaceutical Inc. Eric Crombez; Chief Medical Officer & Executive VP; Ultragenyx Pharmaceutical Inc. Erik Harris ...
Feb 8-Japan's Nikkei leaps to 2-week high on tech stocks, yen boost
Reuters via Yahoo Singapore Finance· 6 months ago(Corrects analyst's name to Kenji Abe from Shinji Abe) By Kevin Buckland TOKYO (Reuters) -Japan's...
Ultragenyx (RARE) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo Singapore Finance· 9 months agoUltragenyx (RARE) reports weaker-than-expected third-quarter 2023 results, missing earnings and...
Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin
Zacks via Yahoo Singapore Finance· 10 months agoOrchard (ORTX) is set to be acquired by Kyowa Kirin for a consideration of $17 per American...
Orchard Therapeutics PLC Sponsored ADR (ORTX) Surges 96.0%: Is This an Indication of Further Gains?
Zacks via Yahoo Singapore Finance· 10 months agoOrchard Therapeutics PLC Sponsored ADR (ORTX) was a big mover last session on higher-than-average...